[Molecular action of drugs affecting platelet functions (author's transl)].
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000991:Antithrombins / Q000494:pharmacology; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D000242:Cyclic AMP / Q000097:blood; D016861:Cyclooxygenase Inhibitors; D011464:Epoprostenol / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D010740:Phospholipases / Q000037:antagonists & inhibitors; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000096:biosynthesis; D013927:Thrombosis / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000991:Antithrombins; D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D006493:Heparin; D011464:Epoprostenol; D000242:Cyclic AMP; D010740:Phospholipases; D013930:Thromboxane-A Synthase
Stratégie moléculaires des substances modifiant certaines fonctions plaquettaires.